IBL/Anti-human CD20 (N) (4-6:2C) Mouse IgG/JP10415/
天然蛋白
商品編號(hào)
JP10415
品牌
IBL
公司
IBL,inc
公司分類(lèi)
Immunology / Cytokines
商品信息
Quantity / Tests
100?g
Species / Antigen
Synthetic peptide (CMQSGP
KPL
FRRMSS)
Host
Mouse
Subclass / Clone
IgG3/4-6H:2C
Type
Monoclonal
Purification
Protein A
Label
No
Regulatory Status:
For research use only
Details for:
?
Anti-human CD20 (N) (4-6:2C) Mouse IgG
Rituximab used for treatment of lymphoma is an antibody drug targeting CD20. It has been reported that the C-terminal region of CD20 undertakes a critical role in binding to rituximab and the association between C-terminal mutations and rituximab-resistance has been investigated. This antibody was developed as a new monoclonal antibody that recognizes the N-terminal region of CD20 molecule to detect comprehensive CD20 regardless of C-terminal mutations. It is expected to be useful for the detailed examination of CD20 molecules by adding this antibody to research CD20.
For concrete data please consult the Instruction for Use in the download box on the right side.
產(chǎn)品貨號(hào):待定